444 related articles for article (PubMed ID: 30474570)
1. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
3. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
[TBL] [Abstract][Full Text] [Related]
4. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
5. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
6. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
7. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
8. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression.
Cai X; Nie J; Chen L; Yu F
Mol Genet Genomic Med; 2020 Feb; 8(2):e1093. PubMed ID: 31845519
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
Liu CH; Jing XN; Liu XL; Qin SY; Liu MW; Hou CH
J Ovarian Res; 2020 Aug; 13(1):92. PubMed ID: 32782028
[TBL] [Abstract][Full Text] [Related]
10.
Luan Q; Yang R; Lin L; Li X
Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
13. MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2.
Huang WT; Zhang H; Jin Z; Li K; Hu C; Li ML; Situ J
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4710-4718. PubMed ID: 32432734
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group AT-hook 2 promotes growth and metastasis and is regulated by miR-204-5p in oesophageal squamous cell carcinoma.
Zhang H; Wu X; Sui Z; Ma Z; Gong L; Meng B; Tang P; Yu Z
Eur J Clin Invest; 2021 Aug; 51(8):e13563. PubMed ID: 33901298
[TBL] [Abstract][Full Text] [Related]
15. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression.
Yang X; Zhao Q; Yin H; Lei X; Gan R
J Drug Target; 2017 Aug; 25(7):653-660. PubMed ID: 28436711
[TBL] [Abstract][Full Text] [Related]
16. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2.
Song Z; Liao C; Yao L; Xu X; Shen X; Tian S; Wang S; Xing F
Cancer Gene Ther; 2023 Apr; 30(4):596-607. PubMed ID: 36494581
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.
Du W; Feng Z; Sun Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):198-202. PubMed ID: 30442370
[TBL] [Abstract][Full Text] [Related]
19. [MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].
Huang Z; Shen H; Deng H; Sun L; Qü B
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1389-1396. PubMed ID: 36210713
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]